Skip to main navigation Skip to search Skip to main content

Thrombolytic therapy for acute myocardial infarction in a 110-year-old man

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Age, per se, is not a sufficient reason to exclude patients from thrombolytic therapy, particularly in view of the much greater hospital mortality in the elderly,1 and some studies have shown the relative safety of thrombolytic therapy for acute myocardial infarction in the elderly.2 We report a case in which thrombolytic therapy was administered to a 110-year-old man, the oldest patient known to have received thrombolytic therapy.

Original languageEnglish
Pages (from-to)1122-1123
Number of pages2
JournalAmerican Journal of Cardiology
Volume71
Issue number12
DOIs
StatePublished - 1 May 1993

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Thrombolytic therapy for acute myocardial infarction in a 110-year-old man'. Together they form a unique fingerprint.

Cite this